Technology area: Biotechnology & Pharmaceuticals
24 pending office actions • 2 clients • 22 examiners • 14 art units • 0 of 24 (0%) have an AI response strategy ready • 10 patents granted in the last 365 days
This profile covers Biotechnology & Pharmaceuticals and includes 222 career applications. Its resolved allowance rate is 91.74%, with an average of 5.96 office actions per allowance. The data shows a high reported allowance outcome alongside a comparatively extended sequence of office-action activity in matters that reached allowance.
There are 22 pending office actions, creating a current workload that warrants active docket management. The contrast between the allowance rate and the action average is significant for prosecution planning: favorable resolution has been common in the reported record, but it has typically followed repeated examination events. Practitioners can use that pattern when preparing amendment strategies and budgeting response effort for this technology area.
Based on the USPTO statutory response window for each pending office action. 8 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 8 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 2 (8%) |
| §103 only | 6 (25%) |
| §112 only | 2 (8%) |
| Double-patenting only | 1 (4%) |
| Double-patenting + other | 4 (17%) |
| Multi-statute (no §101) | 7 (29%) |
| No statute on record | 2 (8%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SCHUBERG, LAURA J | 2 | 23.6% | +37.0% |
| CANELLA, KAREN A | 2 | 62.3% | +32.8% |
| ABBOTT, KODYE LEE | 1 | 54.5% | +71.4% |
| MOSHER, ERIC PARKER | 1 | 100.0% | +0.0% |
| MARTIN, PAUL C | 1 | 41.8% | +21.7% |
| TAKENAKA, RISA | 1 | 26.1% | +100.0% |
| LARA, CAROLINE MONSERRAT | 1 | 85.7% | +16.7% |
| GONZALES, JOSEPHINE MARIA | 1 | 28.8% | +34.6% |
| WEHBE, ANNE MARIE SABRINA | 1 | 57.3% | +43.3% |
| STOICA, ELLY GERALD | 1 | 66.8% | +22.6% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18440260 | EFFICIENT DIFFERENTIATION OF SECOND HEART FIELD CARDIAC PROGENITOR CELLS AND RIGHT VENTRICLE CARDIOMYOCYTES FROM HUMAN PLURIPOTENT STEM CELLS | LARA, CAROLINE MONSERRAT | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17820488 | RETINAL ORGANOID MODEL SYSTEMS | HOLLAND, PAUL J | 73d overdue |
| 18094221 | T CELL SPECIFIC BIOMARKERS FOR PREDICTING GRAFT-VS-HOST DISEASE AND HEMATOPOIETIC MALIGNANCY RELAPSE FOLLOWING HEMATOPOIETIC STEM CELL TRANSPLANTATION AND TREATMENT THEREOF | GABEL, GAILENE | 31d overdue |
| 18463211 | REAGENTS AND METHODS FOR PRODUCING ERYTHROMYELOID PROGENITOR CELLS, NK CELLS, AND MEGAKARYOCYTES | SCHUBERG, LAURA J | 18d overdue |
| 17352873 | PLURIPOTENT STEM CELLS OBTAINED BY NON-VIRAL REPORGRAMMING | WILSON, MICHAEL C | 33d |
| 18302636 | COMBINATIONAL IMMUNOTHERAPIES USING CAR-M, CAR-NK, CAR-EOS, AND CAR-N CELLS | MELCHIOR, JAMES RYLAND | 84d |
| 18982272 | Method for the Induction of Arterial-Type of Hemogenic Endothelium from hPSCS | ABBOTT, KODYE LEE | — |
| 18829184 | Methods for In Vivo Tracking of Cells | MOSHER, ERIC PARKER | — |
| 18819158 | Generating Vasculogenic Cell Populations | SCHUBERG, LAURA J | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18463211 | REAGENTS AND METHODS FOR PRODUCING ERYTHROMYELOID PROGENITOR CELLS, NK CELLS, AND MEGAKARYOCYTES | SCHUBERG, LAURA J | 18d overdue |
| 18982272 | Method for the Induction of Arterial-Type of Hemogenic Endothelium from hPSCS | ABBOTT, KODYE LEE | — |
| 18819158 | Generating Vasculogenic Cell Populations | SCHUBERG, LAURA J | — |
| 18770187 | Generation of Adipocytes from Bovine Embryonic Stem Cell Lines | MARTIN, PAUL C | — |
| 18613041 | REAGENTS AND METHODS FOR PROMOTING ARTERIAL ENDOTHELIUM DIFFERENTIATION AND NITRIC OXIDE PRODUCTION | TAKENAKA, RISA | — |
| 18440260 | EFFICIENT DIFFERENTIATION OF SECOND HEART FIELD CARDIAC PROGENITOR CELLS AND RIGHT VENTRICLE CARDIOMYOCYTES FROM HUMAN PLURIPOTENT STEM CELLS | LARA, CAROLINE MONSERRAT | — |
| 18451617 | GENERATION OF THERAPEUTIC CELLS USING EXTRACELLULAR COMPONENTS OF TARGET ORGANS | GONZALES, JOSEPHINE MARIA | — |
| 18351246 | Macrophage Cell Therapy to Treat Orthopedic Injury | WEHBE, ANNE MARIE SABRINA | — |
| Client (Assignee) | Pending OAs |
|---|---|
| Wisconsin Alumni Research Foundation | 23 |
| Wisconsin Alumni Research Foundation | 1 |
| Art Unit | Apps |
|---|---|
| 1631 | 4 |
| 1632 | 3 |
| 1653 | 3 |
| 1633 | 2 |
| 1643 | 2 |
| 1612 | 1 |
| 1634 | 1 |
| 1618 | 1 |
| 1644 | 1 |
| 3774 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 18982272 | Method for the Induction of Arterial-Type of Hemogenic Endothelium from hPSCS | Wisconsin Alumni Research Foundation | ABBOTT, KODYE LEE | 1632 | §103§112Other | Non-Final OA | — | Pending | Dec 16, 2024 |
| 18829184 | Methods for In Vivo Tracking of Cells | Wisconsin Alumni Research Foundation | MOSHER, ERIC PARKER | 1612 | §103§112 | Non-Final OA | — | Pending | Sep 09, 2024 |
| 18819158 | Generating Vasculogenic Cell Populations | Wisconsin Alumni Research Foundation | SCHUBERG, LAURA J | 1631 | §103§112DP | Non-Final OA | — | Pending | Aug 29, 2024 |
| 18770187 | Generation of Adipocytes from Bovine Embryonic Stem Cell Lines | Wisconsin Alumni Research Foundation | MARTIN, PAUL C | §103§112 | Non-Final OA | — | Pending | Jul 11, 2024 | |
| 18613041 | REAGENTS AND METHODS FOR PROMOTING ARTERIAL ENDOTHELIUM DIFFERENTIATION AND NITRIC OXIDE PRODUCTION | Wisconsin Alumni Research Foundation | TAKENAKA, RISA | 1653 | §102§103§112 | Non-Final OA | — | Pending | Mar 21, 2024 |
| 18440260 | EFFICIENT DIFFERENTIATION OF SECOND HEART FIELD CARDIAC PROGENITOR CELLS AND RIGHT VENTRICLE CARDIOMYOCYTES FROM HUMAN PLURIPOTENT STEM CELLS | Wisconsin Alumni Research Foundation | LARA, CAROLINE MONSERRAT | 1633 | §102§112DP | Non-Final OA | — | Pending | Feb 13, 2024 |
| 18463211 | REAGENTS AND METHODS FOR PRODUCING ERYTHROMYELOID PROGENITOR CELLS, NK CELLS, AND MEGAKARYOCYTES | Wisconsin Alumni Research Foundation | SCHUBERG, LAURA J | 1631 | §102§112 | Final Rejection | 18d overdue | Pending | Sep 07, 2023 |
| 18451617 | GENERATION OF THERAPEUTIC CELLS USING EXTRACELLULAR COMPONENTS OF TARGET ORGANS | Wisconsin Alumni Research Foundation | GONZALES, JOSEPHINE MARIA | 1631 | §103 | Non-Final OA | — | Pending | Aug 17, 2023 |
| 18351246 | Macrophage Cell Therapy to Treat Orthopedic Injury | Wisconsin Alumni Research Foundation | WEHBE, ANNE MARIE SABRINA | 1634 | §112 | Non-Final OA | — | Pending | Jul 12, 2023 |
| 18345385 | Targeted Radiotherapy Chelates for In Situ Immune Modulated Cancer Vaccination | Wisconsin Alumni Research Foundation | CANELLA, KAREN A | 1643 | DP | Non-Final OA | — | Pending | Jun 30, 2023 |
| 18332457 | Fibroblast Activation ImmunoPET for Detection of Fibrosis Activity | Wisconsin Alumni Research Foundation | STOICA, ELLY GERALD | 1618 | §103§112DP | Non-Final OA | — | Pending | Jun 09, 2023 |
| 18310510 | GENERATING ARTERIAL ENDOTHELIAL CELL POPULATIONS | Wisconsin Alumni Research Foundation | NGUYEN, NGHI V | 1653 | §103 | Final Rejection | 5d overdue | Pending | May 01, 2023 |
| 18302636 | COMBINATIONAL IMMUNOTHERAPIES USING CAR-M, CAR-NK, CAR-EOS, AND CAR-N CELLS | Wisconsin Alumni Research Foundation | MELCHIOR, JAMES RYLAND | 1644 | §103§112 | Non-Final OA | 84d | Pending | Apr 18, 2023 |
| 18297417 | GENERATING ALLOGENIC ENDOTHELIAL CELL-SEEDED VASCULAR GRAFTS AND METHODS OF USE THEREOF | Wisconsin Alumni Research Foundation | BLANCO, JAVIER G | 3774 | §103 | Final Rejection | 39d | Pending | Apr 07, 2023 |
| 18182850 | Using Targeted Radiotherapy (TRT) to Drive Anti-Tumor Immune Response to Immunotherapies | Wisconsin Alumni Research Foundation | CANELLA, KAREN A | 1643 | Other | Non-Final OA | — | Pending | Mar 13, 2023 |
| 18094221 | T CELL SPECIFIC BIOMARKERS FOR PREDICTING GRAFT-VS-HOST DISEASE AND HEMATOPOIETIC MALIGNANCY RELAPSE FOLLOWING HEMATOPOIETIC STEM CELL TRANSPLANTATION AND TREATMENT THEREOF | Wisconsin Alumni Research Foundation | GABEL, GAILENE | 1678 | §101§103 | Final Rejection | 31d overdue | Pending | Jan 06, 2023 |
| 17973020 | Simplified Compositions and Methods for Generating Neural Stem Cells from Human Pluripotent Stem Cells | Wisconsin Alumni Research Foundation | DUTT, ADITI | 1675 | §112DP | Non-Final OA | — | Pending | Oct 25, 2022 |
| 17963806 | DERIVATION OF HEPATOCYTES AND HEMATOPOIETIC PROGENITORS FROM HUMAN EMBRYONIC STEM CELLS | Wisconsin Alumni Research Foundation | PARAS JR, PETER | 1632 | Other | Final Rejection | — | Pending | Oct 11, 2022 |
| 17820488 | RETINAL ORGANOID MODEL SYSTEMS | Wisconsin Alumni Research Foundation | HOLLAND, PAUL J | 1656 | §101§103 | Final Rejection | 73d overdue | Pending | Aug 17, 2022 |
| 17863363 | LPS Priming of Stromal Cells to Generate LPS-Specific Exosome Educated Macrophages | Wisconsin Alumni Research Foundation | FOX, ALLISON M | 1633 | §112Other | Final Rejection | 37d overdue | Pending | Jul 12, 2022 |
| 17545416 | METHODS FOR CONTROLLED INDUCTION OF BIOENGINEERED NEUROEPITHELIAL TISSUES AND 3-D NEUROEPITHELIAL TUBES | Wisconsin Alumni Research Foundation | STAVROU, CONSTANTINA E | 1632 | §103 | Non-Final OA | — | Pending | Dec 08, 2021 |
| 17352873 | PLURIPOTENT STEM CELLS OBTAINED BY NON-VIRAL REPORGRAMMING | Wisconsin Alumni Resarch Foundation | WILSON, MICHAEL C | 1638 | §103§112 | Non-Final OA | 33d | Pending | Jun 21, 2021 |
| 17343647 | COMPOSITIONS AND METHODS FOR PRECISE PATTERNING OF POSTERIOR NEUROECTODERM FROM HUMAN PLURIPOTENT STEM CELLS | Wisconsin Alumni Research Foundation | WILLIAMS, EMMALEE RAE | 1653 | §103 | Final Rejection | — | Pending | Jun 09, 2021 |
| 17117062 | IN VITRO EXPANSION OF DOPAMINERGIC SUBTYPE NEURONAL PROGENITORS DERIVED FROM PLURIPOTENT STEM CELLS | Wisconsin Alumni Research Foundation | MIANO, JOSEPH PAUL | 1631 | §103 | Non-Final OA | — | Pending | Dec 09, 2020 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial91.7% of resolved applications prosecuted by Mbhb - Warf were allowed, across 222 applications in USPTO records.
5.96 office actions per allowed application on average.
24 pending office actions as of October 2026, for 2 clients, before 22 examiners in 14 art units.
